• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯妊娠以及轻度和中度子痫前期中的C1酯酶抑制剂

C1-esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsia.

作者信息

Halbmayer W M, Hopmeier P, Mannhalter C, Heuss F, Leodolter S, Rubi K, Fischer M

机构信息

Central Laboratory, Municipal Hospital of the City of Vienna-Lainz, Austria.

出版信息

Thromb Haemost. 1991 Feb 12;65(2):134-8.

PMID:2053098
Abstract

Routine coagulation tests and measurement of the plasma levels of C1-esterase inhibitor (C1-INH) and antithrombin III were performed in 17 women with mild preeclampsia, 10 women with moderate preeclampsia and 20 women with uncomplicated pregnancy. All pregnant probands were within the third trimester of pregnancy. 20 non-pregnant women were used as controls. The groups were matched in age and the pregnant ones were also matched in gestational age. C1-INH activity and antigen were significantly reduced (p less than 0.002) in normally pregnant women as compared with non-pregnant ones. Further, C1-INH activity was lower in women with mild preeclampsia and significantly lower in women with moderate preeclampsia (p less than 0.05) as compared with normally pregnant women. None of the plasmatic coagulation tests was indicative of a consumption reaction. We conclude that C1-INH activity and antigen reductions are commonly associated with pregnancy. Furthermore, as markedly lower values can be found in mild and moderate preeclampsia, measurement of the C1-INH activity in pregnant women within the third trimester might proof useful to establish the diagnosis of a preeclamptic condition.

摘要

对17例轻度子痫前期孕妇、10例中度子痫前期孕妇和20例正常妊娠孕妇进行了常规凝血试验,并检测了血浆中C1酯酶抑制剂(C1-INH)和抗凝血酶III的水平。所有孕妇均处于妊娠晚期。选取20例非妊娠女性作为对照。各研究组年龄匹配,孕妇的孕周也相互匹配。与非妊娠女性相比,正常妊娠女性的C1-INH活性和抗原显著降低(p<0.002)。此外,与正常妊娠女性相比,轻度子痫前期女性的C1-INH活性较低,中度子痫前期女性的C1-INH活性显著更低(p<0.05)。所有血浆凝血试验均未提示存在消耗反应。我们得出结论,C1-INH活性和抗原降低通常与妊娠有关。此外,由于在轻度和中度子痫前期可发现C1-INH活性值明显更低,因此在妊娠晚期测量孕妇的C1-INH活性可能有助于子痫前期的诊断。

相似文献

1
C1-esterase inhibitor in uncomplicated pregnancy and mild and moderate preeclampsia.单纯妊娠以及轻度和中度子痫前期中的C1酯酶抑制剂
Thromb Haemost. 1991 Feb 12;65(2):134-8.
2
Activation of the complement system in normal pregnancy and preeclampsia.正常妊娠和子痫前期中补体系统的激活。
Mol Immunol. 2010 Apr;47(7-8):1500-6. doi: 10.1016/j.molimm.2010.01.021. Epub 2010 Feb 23.
3
Antithrombin III activity in women with hypertension during pregnancy.妊娠期高血压女性的抗凝血酶III活性
Obstet Gynecol. 1985 Mar;65(3):301-6.
4
Coagulation inhibitors in preeclamptic pregnant women.子痫前期孕妇的凝血抑制剂
Arch Gynecol Obstet. 2005 Mar;271(3):227-30. doi: 10.1007/s00404-003-0596-4. Epub 2004 Jan 21.
5
The predictive value of the hemostasis parameters in the development of preeclampsia.
Thromb Haemost. 1992 Feb 3;67(2):214-8.
6
Low plasma levels of oxidized low density lipoprotein in preeclampsia.子痫前期患者血浆中氧化型低密度脂蛋白水平较低。
Acta Obstet Gynecol Scand. 2004 Dec;83(12):1173-7. doi: 10.1111/j.0001-6349.2004.00539.x.
7
Markers of inflammation in preeclampsia.子痫前期的炎症标志物。
Prague Med Rep. 2004;105(3):301-10.
8
[Plasma concentration of biochemical markers in pre-eclampsia-eclampsia and its association with the severity of the disease].[子痫前期-子痫患者血浆生化标志物浓度及其与疾病严重程度的关联]
Ginecol Obstet Mex. 2000 Sep;68:385-93.
9
Plasma and platelet norepinephrine in normal and preeclamptic pregnancy.正常妊娠和子痫前期妊娠中的血浆及血小板去甲肾上腺素
J Reprod Med. 1987 Jul;32(7):504-8.
10
Serum levels of leukocyte functional antigen-3 in pregnancy and preeclampsia.妊娠和子痫前期患者血清白细胞功能抗原-3水平
Acta Obstet Gynecol Scand. 1999 Aug;78(7):580-5.

引用本文的文献

1
Depressed Kallikrein Generation in Women With Preeclampsia: A Matched Cross-Sectional Study.子痫前期女性中激肽释放酶生成减少:一项匹配横断面研究。
Front Med (Lausanne). 2022 Jun 6;9:896811. doi: 10.3389/fmed.2022.896811. eCollection 2022.
2
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.国际血管性水肿学会(WAO)/欧洲变态反应和临床免疫学会(EAACI)遗传性血管性水肿管理指南——2021年修订与更新
World Allergy Organ J. 2022 Apr 7;15(3):100627. doi: 10.1016/j.waojou.2022.100627. eCollection 2022 Mar.
3
Management of hereditary angioedema in pregnant women: a review.
妊娠期遗传性血管性水肿的管理:综述。
Int J Womens Health. 2014 Sep 9;6:839-48. doi: 10.2147/IJWH.S46460. eCollection 2014.
4
Angioedema with normal laboratory values: the next step.血管性水肿伴正常实验室值:下一步。
Curr Allergy Asthma Rep. 2013 Oct;13(5):563-70. doi: 10.1007/s11882-013-0383-7.
5
Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions.因子 XII 突变、雌激素依赖性遗传性血管性水肿及相关疾病。
Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):16. doi: 10.1186/1710-1492-6-16.
6
Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.子痫前期和小于胎龄儿的妊娠具有不同的补体裂解产物谱。
J Matern Fetal Neonatal Med. 2010 Jul;23(7):646-57. doi: 10.3109/14767050903301009.
7
Normal pregnancy is characterized by systemic activation of the complement system.正常妊娠的特征是补体系统的全身激活。
J Matern Fetal Neonatal Med. 2005 Apr;17(4):239-45. doi: 10.1080/14767050500072722.
8
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.遗传性和获得性血管性水肿:问题与进展:第三届C1酯酶抑制剂缺乏症研讨会及后续会议论文集
J Allergy Clin Immunol. 2004 Sep;114(3 Suppl):S51-131. doi: 10.1016/j.jaci.2004.06.047.